Our findings have several implications for the expanding role of GLP-1 RAs in the management of obesity and cardiometabolic disease that underscore the need to understand patient perceptions to guide clinical decision-making, research, and policy efforts. This evidence concerns the gene GLP1R and obesity disorder.